A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis

Human Molecular Genetics

Volumn 23, Issue 2, 2014, Pages 355-367

  Chu, Hou Wei ^a,b   Cheng, Chun Wen ^c   Chou, Wen Cheng ^b   Hu, Ling Yueh ^b   Wang, Hsiao Wei ^b   Hsiung, Chia Ni ^b   Hsu, Huan Ming ^d   Wu, Pei Ei ^b   Hou, Ming Feng ^e   Shen, Chen Yang ^a,b,f   Yu, Jyh Cherng ^d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MICRORNA; MICRORNA 190A; PROTEINASE ACTIVATED RECEPTOR 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PATIENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 15; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HUMANS; LYMPHATIC METASTASIS; MCF-7 CELLS; MICRORNAS; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; QUANTITATIVE TRAIT LOCI; RECEPTOR, PAR-1; SIGNAL TRANSDUCTION;

EID: 84893426809     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt426     Document Type: Article

References (54)

1. Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., Milne, R.L., Schmidt, M.K., Chang-Claude, J., Bojesen, S.E., Bolla, M.K. et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet., 45, 353-361, 361e 351-352.
2. Bojesen, S.E., Pooley, K.A., Johnatty, S.E., Beesley, J., Michailidou, K., Tyrer, J.P., Edwards, S.L., Pickett, H.A., Shen, H.C., Smart, C.E. et al. (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet., 45, 371-384, 384 e371-372.
3. Zheng, W., Zhang, B., Cai, Q., Sung, H., Michailidou, K., Shi, J., Choi, J.Y., Long, J., Dennis, J., Humphreys, M.K. et al. (2013) Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum. Mol. Genet., 22, 2539-2550.
4. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
5. Carter, C.L., Allen, C. and Henson, D.E. (1989) Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer, 63, 181-187.
6. Cheng, Y.C., Hsiao, F.C., Yeh, E.C., Lin, W.J., Tang, C.Y., Tseng, H.C.,Wu, H.T., Liu, C.K., Chen, C.C., Chen, Y.T. et al. (2012) Variowatch: providing large-scale and comprehensive annotations on human genomic variants in the next generation sequencing era. Nucleic Acids Res., 40, W76-W81.
7. Ma, L., Teruya-Feldstein, J. and Weinberg, R.A. (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682-688.
8. Bourguignon, L.Y., Wong, G., Earle, C., Krueger, K. and Spevak, C.C. (2010) Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J. Biol. Chem., 285, 36721-36735.
9. Haque, I., Banerjee, S., Mehta, S., De, A., Majumder, M., Mayo, M.S., Kambhampati, S., Campbell, D.R. and Banerjee, S.K. (2011) Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells. J. Biol. Chem., 286, 43475-43485.
10. Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M., Spruce, T. et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell, 141, 1195-1207.
11. Liang, Y.J.,Wang,Q.Y., Zhou, C.X., Yin, Q.Q., He, M., Yu, X.T., Cao, D.X., Chen, G.Q., He, J.R. and Zhao, Q. (2013) MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis, 34, 713-722.
12. Zhang, Y., Yan, L.X., Wu, Q.N., Du, Z.M., Chen, J., Liao, D.Z., Huang, M.Y., Hou, J.H., Wu, Q.L., Zeng, M.S. et al. (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res., 71, 3552-3562.
13. Tang, F., Zhang, R., He, Y., Zou, M., Guo, L. and Xi, T. (2012) MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS ONE, 7, e35435.
14. Hurst, D.R., Edmonds, M.D., Scott, G.K., Benz, C.C., Vaidya, K.S. and Welch, D.R. (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res., 69, 1279-1283.
15. Li, Y., Zhang, M., Chen, H., Dong, Z., Ganapathy, V., Thangaraju, M. and Huang, S. (2010) Ratio of miR-196 s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res., 70, 7894-7904.
16. Consortium, T.E.P. (2011) A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol., 9, e1001046.
17. Chen, H.W., Lee, J.Y., Huang, J.Y., Wang, C.C., Chen, W.J., Su, S.F., Huang, C.W., Ho, C.C., Chen, J.J., Tsai, M.F. et al. (2008) Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res., 68, 7428-7438.
18. Pan, S.H., Chao, Y.C., Hung, P.F., Chen, H.Y., Yang, S.C., Chang, Y.L.,Wu, C.T., Chang, C.C., Wang, W.L., Chan, W.K. et al. (2011) The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. J. Clin. Invest., 121, 3189-3205.
19. Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
20. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell, 115, 787-798.
21. Kamath, L., Meydani, A., Foss, F. and Kuliopulos, A. (2001) Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res., 61, 5933-5940.
22. Yang, E., Boire, A., Agarwal, A., Nguyen, N., O'Callaghan, K., Tu, P., Kuliopulos, A. and Covic, L. (2009) Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res., 69, 6223-6231.
23. Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I. and Bar-Shavit, R. (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med., 4, 909-914.
24. Eroglu, A., Karabiyik, A. and Akar, N. (2011) The association of protease activated receptor 1 gene-506 I/D polymorphismwith disease-free survival in breast cancer patients. Ann. Surg. Oncol., 19, 1365-1369.
25. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S. and Kuliopulos, A. (2005) PAR1 Is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell, 120, 303-313.
26. Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjarn, M., Hansen, H.F., Berger, U. et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature, 452, 896-899.
27. Corcoran, D.L., Pandit, K.V., Gordon, B., Bhattacharjee, A., Kaminski, N. and Benos, P.V. (2009) Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE, 4, e5279.
28. Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C. and Snyder, M. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
29. Marino, M., Galluzzo, P. and Ascenzi, P. (2006) Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics, 7, 497-508.
30. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.R. and Chambon, P. (1987) Functional domains of the human estrogen receptor. Cell, 51, 941-951.
31. Lin, C.Y., Vega, V.B., Thomsen, J.S., Zhang, T., Kong, S.L., Xie, M., Chiu, K.P., Lipovich, L., Barnett, D.H., Stossi, F. et al. (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet., 3, e87.
32. Volinia, S., Galasso, M., Sana, M.E., Wise, T.F., Palatini, J., Huebner, K. and Croce, C.M. (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc. Natl Acad. Sci. USA, 109, 3024-3029.
33. Giamarchi, C., Solanas, M., Chailleux, C., Augereau, P., Vignon, F., Rochefort, H. and Richard-Foy, H. (1999) Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and-independent breast cancer cell lines. Oncogene, 18, 533-541.
34. Cheng, C.W., Yu, J.C., Wang, H.W., Huang, C.S., Shieh, J.C., Fu, Y.P., Chang, C.W., Wu, P.E. and Shen, C.Y. (2010) The clinical implications of MMP-11 and CK-20 expression in human breast cancer. Clin. Chim. Acta, 411, 234-241.
35. Fugger, L., McVean, G. and Bell, J.I. (2012) Genomewide association studies and common disease-realizing clinical utility. N. Engl. J. Med., 367, 2370-2371.
36. Castellano, L., Giamas, G., Jacob, J., Coombes, R.C., Lucchesi, W., Thiruchelvam, P., Barton, G., Jiao, L.R., Wait, R., Waxman, J. et al. (2009) The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl Acad. Sci. USA, 106, 15732-15737.
37. Di Leva, G., Gasparini, P., Piovan, C., Ngankeu, A., Garofalo, M., Taccioli, C., Iorio, M.V., Li, M., Volinia, S., Alder, H. et al. (2010) MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl Cancer Inst., 102, 706-721.
38. de Souza Rocha Simonini, P., Breiling, A., Gupta, N., Malekpour, M., Youns, M., Omranipour, R., Malekpour, F., Volinia, S., Croce, C.M., Najmabadi, H. et al. (2010) Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res., 70, 9175-9184.
39. Foulkes, W.D., Smith, I.E. and Reis-Filho, J.S. (2010) Triple-negative breast cancer. N. Engl. J. Med., 363, 1938-1948.
40. Garcia, M., Derocq, D., Freiss, G. and Rochefort, H. (1992) Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl Acad. Sci. USA, 89, 11538-11542.
41. Long, B.J. and Rose, D.P. (1996) Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER. Cancer Lett., 99, 209-215.
42. Platet, N., Cunat, S., Chalbos, D., Rochefort, H. and Garcia, M. (2000) Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol. Endocrinol., 14, 999-1009.
43. Sisci, D., Aquila, S., Middea, E., Gentile, M., Maggiolini, M., Mastroianni, F., Montanaro, D. and Ando, S. (2004) Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility. Oncogene, 23, 8920-8930.
44. Maynadier, M., Chambon, M., Basile, I., Gleizes, M., Nirde, P., Gary-Bobo, M. and Garcia, M. (2012) Estrogens promote cell-cell adhesion of normal and malignant mammary cells through increased desmosome formation. Mol. Cell Endocrinol., 364, 126-133.
45. Munster, P.N. and Carpenter, J.T. (2009) Estradiol in breast cancer treatment: reviving the past. JAMA, 302, 797-798.
46. Maynadier, M., Ramirez, J.M., Cathiard, A.M., Platet, N., Gras, D., Gleizes, M., Sheikh, M.S., Nirde, P. and Garcia, M. (2008) Unliganded estrogen receptor alpha inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21(WAF1)). FASEB J., 22, 671-681.
47. Zheng, H., Chu, J., Zeng, Y., Loh, H.H. and Law, P.Y. (2010) Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J. Biol. Chem., 285, 21994-22002.
48. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M.J. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
49. Gupta, G.P. and Massague, J. (2006) Cancer metastasis: building a framework. Cell, 127, 679-695.
50. Ding, S.L., Yu, J.C., Chen, S.T., Hsu, G.C., Hsu, H.M., Ho, J.Y., Lin, Y.H., Chang, C.C., Fann, C.S., Cheng, C.W. et al. (2010) Diverse associations between ESR1 polymorphism and breast cancer development and progression. Clin. Cancer Res., 16, 3473-3484.
51. Lo, Y.L. and Shen, C.Y. (2002) Laser capture microdissection in carcinoma analysis. Methods Enzymol., 356, 137-144.
52. Cheng, C.W., Wang, H.W., Chang, C.W., Chu, H.W., Chen, C.Y., Yu, J.C., Chao, J.I., Liu, H.F., Ding, S.L. and Shen, C.Y. (2012) MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res. Treat., 134, 1081-1093.
53. Yu, J.C., Hsiung, C.N., Hsu, H.M., Bao, B.Y., Chen, S.T., Hsu, G.C., Chou, W.C., Hu, L.Y., Ding, S.L., Cheng, C.W. et al. (2011) Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Res., 13, R13.
54. Chou, W.C., Wang, H.C., Wong, F.H., Ding, S.L., Wu, P.E., Shieh, S.Y. and Shen, C.Y. (2008) Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. EMBO J., 27, 3140-3150.